Naslov
Systematic Review of Artificial Intelligence in Acute Respiratory Distress Syndrome for COVID-19 Lung Patients: A Biomedical Imaging Perspective

Autori
Suri, Jasjit ; Agarwal, Sushant ; Gupta, Suneet ; Puvvula, Anudeep ; Višković, Klaudija ; Suri, Neha ; Alizad, Azra ; El-Baz, Ayman ; Saba, Luca ; Fatemi, Mostafa ; Naidu, D. Subbaram

Izvornik
IEEE Journal of Biomedical and Health Informatics (2168-2194) 25 (2021), 11; 4128-4139

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Artificial intelligence ; Acute Respiratory Distress Syndrome ; COVID-19 ; lung ; biomedical imaging perspective

Sažetak
SARS-CoV-2 has infected over ∼165 million people worldwide causing Acute Respiratory Distress Syndrome (ARDS) and has killed ∼3.4 million people. Artificial Intelligence (AI) has shown to benefit in the biomedical image such as X- ray/Computed Tomography in diagnosis of ARDS, but there are limited AI-based systematic reviews (aiSR). The purpose of this study is to understand the Risk-of- Bias (RoB) in a non-randomized AI trial for handling ARDS using novel AtheroPoint- AI-Bias (AP(ai)Bias). Our hypothesis for acceptance of a study to be in low RoB must have a mean score of 80% in a study. Using the PRISMA model, 42 best AI studies were analyzed to understand the RoB. Using the AP(ai)Bias paradigm, the top 19 studies were then chosen using the raw- cutoff of 1.9. This was obtained using the intersection of the cumulative plot of “mean score vs. study” and score distribution. Finally, these studies were benchmarked against ROBINS-I and PROBAST paradigm. Our observation showed that AP(ai)Bias, ROBINS-I, and PROBAST had only 32%, 16%, and 26% studies, respectively in low-moderate RoB (cutoff>2.5), however none of them met the RoB hypothesis. Further, the aiSR analysis recommends six primary and six secondary recommendations for the non-randomized AI for ARDS. The primary recommendations for improvement in AI-based ARDS design inclusive of (i) comorbidity, (ii) inter- and intra-observer variability studies, (iii) large data size, (iv) clinical validation, (v) granularity of COVID-19 risk, and (vi) cross- modality scientific validation. The AI is an important component for diagnosis of ARDS and the recommendations must be followed to lower the RoB.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA